FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsMeamo
Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsMJS Medicals
FDA warned South Korea's MJS Medicals for selling unapproved, misbranded botulinum toxin ("Innotox") to U.S. consumers online.
High risk -
DrugsDerma Solution
FDA warned Derma Solution for selling unapproved, misbranded injectable Botulax botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsGlowface
Glowface's website sells unapproved, misbranded injectable Botulax botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsApotex Inc.
FDA cited Apotex's Richmond Hill sterile plant for failed investigations and aseptic contamination risks, prompting recalls.
High risk -
DrugsLiebel-Flarsheim Company LLC
Liebel-Flarsheim's Raleigh, NC sterile drug plant failed to investigate microbial and endotoxin test failures and let cleanrooms and equipment fall into disrepair.
High risk -
Drugsonlineotcmeds.com
FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.
High risk -
DrugsScientific Protein Laboratories, LLC
FDA warns Scientific Protein Laboratories over manufacturing failures in animal-derived APIs, including equipment particles and inadequate investigations.
High risk -
DrugsKath Khemicals LLC
FDA: Kath Khemicals, an OTC hand soap maker in Macomb, MI, released drugs without finished-product or glycerin identity testing.
High risk -
DrugsThe Tranzonic Companies/Innocore Sales & Marketing Inc.
FDA says Innocore Sales & Marketing, an over-the-counter drug manufacturer, lacked finished-product, component, stability and quality-unit controls.
High risk -
DrugsAcme United Corporation
Acme United Corporation made antiseptic wipes with contaminated water and released sterile drugs without sterility testing.
High risk -
DrugsFoshan Yiying Hygiene Products Co., Ltd.
Foshan Yiying, a Chinese OTC drug maker, lacked finished-product testing, stability data and process validation; FDA has blocked its imports.
High risk -
DrugsMelcare Biomedical Pty Ltd
Australia's Melcare Biomedical sells Optimel Manuka+ eye gel and drops in the US as unapproved drugs with honey as an active ingredient.
High risk -
Drugswww.usmedschoice.com
FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.
High risk -
DrugsGuangxi Yulin Pharmaceutical Group Co. Ltd.
FDA warned Guangxi Yulin Pharmaceutical Group that its OTC drugs lacked release testing and had data integrity failures.
High risk -
DrugsBRS Analytical Services, LLC
BRS Analytical Services, LLC made sterile OTC drugs in an unsuitable aseptic facility and recalled them over sterility assurance.
High risk -
DrugsHealth and Natural Beauty USA Corp.
FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.
High risk -
DrugsNaturich Cosmetique Labs
FDA warned Naturich Cosmetique Labs over inadequate manufacturing controls for over-the-counter topical drugs, including contaminated water and untested ingredients.
High risk -
DrugsCreative Essences, Inc.
FDA warns Creative Essences over OTC drug manufacturing failures and an unapproved antiseptic.
High risk -
DrugsDixon Investments Inc. dba ARI
FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.
High risk -
DrugsPersōn & Covey, Inc.
FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.
High risk -
DrugsPamela K. Den Besten, DDS, MS
FDA warned sponsor-investigator Pamela K. Den Besten for running a pediatric dental gel study without an IND, enrolling 43 subjects.
High risk -
DrugsRalph A. DeFronzo, M.D.
FDA warns Dr. Ralph A. DeFronzo for enrolling ineligible subjects and failing to promptly report study changes to the IRB.
High risk -
DrugsStellalife, Inc.
FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.
High risk -
DrugsMedia Networks Sydney Pty. Limited
FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.
High risk -
DrugsChengdu Brilliant Biopharmaceutical Co., Ltd.
FDA warns Chengdu Brilliant over CGMP failures in semaglutide API, including no process validation and missing raw-material identity tests.
High risk -
Drugsmotionpharmacy.com
FDA warns motionpharmacy.com over selling unapproved and misbranded prescription drugs online.
High risk -
DrugsPureRawz
FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.
High risk -
Drugscheaptrustedpharmacy.com
cheaptrustedpharmacy.com sells unapproved, misbranded prescription drugs to U.S. consumers online, FDA warns.
High risk -
DrugsJanssen Vaccines Corp., A Johnson & Johnson Company
FDA warned Janssen Vaccines over inadequate investigations of stopper complaints and missed regulatory notifications for its injection drug.
Medium -
DrugsColumbia Cosmetics Manufacturing Inc.
Columbia Cosmetics Manufacturing Inc. made OTC sunscreen drugs without adequate current good manufacturing practice, including failed out-of-specification investigations and untested high-risk ingredients.
High risk -
DrugsGet.Fit.Medical, LLC dba Get.Fit.Medical
FDA warned Get.Fit.Medical that its website sold compounded sildenafil, tadalafil, semaglutide and tirzepatide with false 'generic' claims.
High risk -
DrugsFWD Care, Inc. dba FWD
FDA warned telehealth company FWD Care that its website claims for compounded semaglutide and tirzepatide drugs are false or misleading.
Medium -
DrugsExpert Aesthetics
FDA warned Expert Aesthetics over website claims that its compounded semaglutide and tirzepatide are generic Ozempic and Mounjaro.
Low -
DrugsDermacare LLC dba BlueChew
FDA warned BlueChew over website claims that its compounded sildenafil and tadalafil are the same as Viagra and Cialis.
High risk -
DrugsHealthy Living Clinic
FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.
Low -
DrugsHims & Hers Health, Inc. dba Hers
FDA warned Hims & Hers (Hers) that its website misleads consumers about compounded semaglutide by implying it is the same as approved Ozempic and Wegovy.
Medium -
DrugsAmazing Meds
FDA warned online seller Amazing Meds over unapproved compounded retatrutide and a misleading "same as Ozempic/Wegovy" semaglutide claim.
High risk -
DrugsGenLabMeds
GenLabMeds offered compounded retatrutide, semaglutide and tirzepatide online as unapproved, misbranded drugs with false or misleading claims.
High risk -
DrugsFitRX, LLC dba Zealthy
FDA warns Zealthy over website claims that compounded semaglutide is the same as Wegovy and Ozempic.
Medium -
DrugsLean Dreams LLC dba LeanDreams
FDA warned LeanDreams over website claims that compounded semaglutide and tirzepatide match FDA-approved Ozempic, Wegovy, Mounjaro and Zepbound.
Low -
Drugsybycmeds
FDA warns ybycmeds over website claims that compounded semaglutide and tirzepatide are similar to approved brand-name drugs.
Medium -
DrugsiVisitDoc, Inc. dba iVisitDoc
FDA warns iVisitDoc over website claims that compounded semaglutide is equivalent to Wegovy and Ozempic, calling the drugs misbranded.
Medium -
DrugsTry Nova
FDA warned Try Nova that its website’s compounded semaglutide claim "Same active ingredient as Wegovy & Ozempic" is false or misleading.
Low -
DrugsLovely Meds, Inc. dba Lovely Meds
FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.
Low -
DrugsThe HCG Institute
FDA warns The HCG Institute over misleading claims for compounded semaglutide sold online.
High risk -
DrugsVitals RX
FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.
Medium -
DrugsTuyo Health, Inc. dba Tuyo Health
FDA warns Tuyo Health over misleading claims for compounded semaglutide and tirzepatide sold online.
Medium -
DrugsLas Villas Health Care LLC dba Villas Health
FDA warned Villas Health over website claims for compounded semaglutide and sildenafil, calling the drugs misbranded and unapproved.
High risk -
DrugsLyfe Rx
Lyfe Rx offered compounded semaglutide and tirzepatide online with false 'clinically proven weight loss' claims, FDA says.
Low